What defines Type 1 borosilicate glass vials for lyophilised peptides?
Type I glass, often printed Type 1, is the pharmacopoeial class for borosilicate container glass of high hydrolytic resistance. The class describes composition family and behaviour under water attack. It does not describe the peptide. Soda-lime containers, Type II when the inner surface has been processed and Type III when it has not, hold a larger alkali inventory and a higher expansion coefficient. Record the printed class exactly, including a suffix such as Type 1A. Delamination work has used Type 1A for borosilicate vials that contained frozen protein formulations, a narrower label than a generic Type I line (Jiang et al., 2013). The network is silica with boron oxide, aluminium oxide, and alkali oxides. Devitrification grows crystals and can leave a surface unlike the parent glass; inhibitors of that crystallisation have been studied in borosilicate compositions (Jean et al., 1995). Recycled borosilicate has also been converted to glass-ceramics in work on chemical durability and low thermal expansion (Saad, 2021). Those ceramics are not Type I vial stock. Read "borosilicate" as amorphous container glass unless a crystalline phase is declared. Lyophilised cakes contact the base and heel, often the most formed regions of a tubular vial, for the life of the lot. Any soluble extract or loose flake from that zone enters the sample when an analytical solution is prepared. Aluminosilicate vials are a different family. Changes reported in aluminosilicate vials during lyophilisation are not a Type I borosilicate specification (Chanda, 2025). An Australian laboratory definition therefore has four lines: composition family, class as printed, forming route, and a statement that the container record is independent of peptide identity and chromatographic purity.
How do flame-ablated surfaces on borosilicate vials differ from the tubing wall?
Tubular vials are not uniform from lip to base. Tubing is drawn, then a flame cuts and forms the mouth, shoulder, and bottom. Those flame-ablated zones see a short, very hot cycle that the mid-wall does not. Analytical transmission electron microscopy has been applied to the flame-ablated surface of borosilicate-glass vials, which suits an altered layer too thin for ordinary light microscopy (Mikamoto et al., 2021). Routine lots do not need that microscopy. They do need a record that the surface under a lyophilised cake is often a formed surface, not the as-drawn composition in a brochure. Flame heating can volatilise boron and alkali. The residue may be richer in silica than the bulk, or it may carry redeposited alkali. Bloom after humid exposure, and a pH shift in a water extract, are screening signs that near-surface alkali is available. They do not name the phase, and they do not replace a hydrolytic-resistance result if the supplier issued one. Particle checks should sample the inner base and heel, not only a mid-wall piece. If the supplier separates tubing conversion from moulded pressing, record the distinction. Pooling both under one Type 1 code hides the surface the solid meets. State tubing or moulded, note any declared dealkalisation or other surface processing, and keep the vial lot beside the peptide lot. Do not call a flame-worked surface inert because the bulk is borosilicate. If an investigation opens, compare energy-dispersive spectra or solution assays for silicon, boron, sodium, and aluminium with a rinse blank from an unused vial of the same lot. Those data characterise the container. They are not a peptide assay.
What delamination mechanism has been reported in Type 1A borosilicate vials after freezing?
Delamination is the release of thin glass flakes from the inner surface. It is not slow dissolution, which can raise silicon in solution without a skin, and it is not a mechanical chip from a cracked heel. In a lyophilised peptide vial, flakes can be mistaken for cake fragments, wipe fibres, or stopper particles. Composition separates them. A glass flake is rich in silicon and often aluminium; a peptide particle is organic and will not match a rinse blank from the same vial lot. A distinct mechanism has been described in Type 1A borosilicate vials that contained frozen protein formulations (Jiang et al., 2013). Lyophilisation starts with freezing. Ice rejects solutes into a shrinking unfrozen fraction, so local pH and ionic strength at the wall can differ from the solution that was filled. The Jiang report is not a lyophilised-peptide study and should not be cited as if it measured a named research peptide. It belongs in the container file because the freeze step is shared. Aluminosilicate vials have been examined for changes during lyophilisation as another glass family (Chanda, 2025). Do not average that report with the Type 1A delamination report and call the result a borosilicate specification. If flakes are suspected, inspect against black and white fields before chromatography. Record morphology and elemental composition before assigning particles to a related-substance profile. A silicon-rich flake does not belong in an HPLC area-percent table. It belongs in a container deviation, cross-referenced to vial lot, closure lot, and peptide lot. The peptide identity result and the fitness of the container lot are separate decisions.
How should laboratories read chemical strengthening of borosilicate vials?
Chemical strengthening of borosilicate vials is an ion-exchange process examined for packaging glass (Abd-Elsatar et al., 2024; Jung et al., 2025). A larger alkali ion from a salt bath replaces a smaller alkali ion in the near-surface network. The surface is left in compression. A crack starting at a flaw must first overcome that compression, so the practical topic is mechanical reliability during capping, tracked dispatch, and bench handling. That topic is not a statement about peptide purity or about any property of the peptide solid. Scratches defeat a compressive layer. Reliability of chemically strengthened borosilicate vials has been assessed under simulated scratching (Jung et al., 2026). A deep scratch can cross the compressed zone and return the glass to flaw-limited fracture behaviour. On a bulk receipt, scuffed shoulders and heel checks are container observations. A broken unit inside a shared overpack is also a possible source of chips in neighbouring vials. Ion exchange and hydrolytic durability answer different questions. Exchange rearranges near-surface alkali, so a hydrolytic-resistance figure measured on untreated tubing does not automatically transfer. Strengthening does not, by itself, move the glass from Type I to another class, and it does not remove a delamination risk set by solution chemistry. A complete line states base glass class, whether ion exchange was declared, and which test was run after the exchange. The peptide certificate of analysis reports identity, chromatographic purity, and content. The vial note reports glass and strengthening. Link them by lot number only. If the manufacturer does not disclose ion exchange, record "not disclosed" rather than assume untreated tubing. A missing statement is still a result.
Which sterilisation and closure records belong with a Type 1 borosilicate vial?
A vial is closed by an elastomer and a seal. For lyophilised peptides that elastomer is often a halobutyl stopper, and the glass and the rubber do not share one thermal history. A sterilisation method has been reported for borosilicate glass vials together with chlorobutyl and bromobutyl rubbers (Karapetyan et al., 2024). Copy the method applied to the lot in hand. Do not read a single paper as a universal cycle. "Sterile because Type I" is not a process. List thermal steps in one column: flame forming, any dealkalisation bake, any glass sterilisation bake, then the lyophilisation cycle the filled unit saw. Elastomers generally cannot follow glass through the same dry-heat range, which is why a method covering glass and both chlorobutyl and bromobutyl rubbers is the relevant scope. Halogen type affects permeability and the extractable profile, so record the polymer as printed on the bill of materials. Closures also contribute volatiles that a peptide method can mistake for process residuals. A residual-solvent headspace run should include a stopper blank and an empty-vial blank from the same lots. Chromatography–mass spectrometry blanks should follow the same diluent path, so a leachable is not integrated as a peptide related substance. Moisture crossing the closure changes Karl Fischer water on the cake; glass type does not measure that water. Sterilisation of a packaging component is a materials and bioburden record. It does not change the research-only status of the peptide, and it does not replace an endotoxin or bioburden result where the laboratory specification calls for one. The container line only stops a reviewer from guessing which rubber and which cycle sat above the cake.
What batch records should an Australian laboratory keep for these vials?
For Type 1 borosilicate glass vials for lyophilised peptides, split the file into three objects: peptide solid, vial, and closure. Concordance means the manufacturer, lot number, and specification for each object sit together on the dispatch record and on the analytical report header. Vial fields: glass class copied as printed; composition family; tubing or moulded; clear or amber; nominal capacity; surface processing (none declared, dealkalisation, or ion exchange); sterilisation process name; hydrolytic-resistance reference if one was issued. Closure fields: polymer, any liner, and lot number. Peptide fields stay on the certificate of analysis: identity method, chromatographic purity, related substances, counter-ion, water, and content. The vial note does not restate them. At receipt, confirm any heel code, closure colour, and seal against the bill of materials. Note haze, cracks, chips, and loose particles before an analytical solution is prepared. Record cake appearance against the peptide cake attributes, and cross-reference if a glass flake is suspected. A mismatch between certificate class and the physical vial is a deviation even when the chromatogram meets its limit. The chromatogram did not inspect the glass. For bulk orders, state whether every vial shares one vial lot. Mixed vial lots under one peptide lot are traceable only when each vial lot is named. Otherwise a delamination investigation cannot be bounded. Local Australian stock and tracked dispatch help when lot numbers are matched before the paperwork leaves the warehouse. Cite flame-surface microscopy, Type 1A frozen-state delamination, ion-exchange work, scratch reliability, aluminosilicate lyophilisation observations, and halobutyl sterilisation only against the question each paper addresses. Do not turn a packaging study into a peptide purity result.
Frequently asked questions
Is Type 1 the same as Type I or Type 1A?
Not always. Type I is the usual pharmacopoeial name for high-hydrolytic-resistance borosilicate container glass, and Type 1 is a common certificate spelling of that class. Type 1A is a narrower label used in delamination work on borosilicate vials that held frozen protein formulations. Copy the designation as printed, and do not collapse suffixes into one row unless the supplier defines them as equivalent.
Does a Type 1 vial show that the peptide lot is pure?
No. Glass class describes the container network and its hydrolytic resistance. Peptide identity, chromatographic purity, related substances, counter-ion, water, and content are measured on the solid and reported on the certificate of analysis. A borosilicate wall can still contribute flakes or soluble extract. Those observations go in a container record. They are not area-percent purity, and they do not replace the peptide methods.
Can aluminosilicate lyophilisation data be used for Type 1 borosilicate vials?
Only as a contrast, not as a specification. Published observations of changes in aluminosilicate vials during lyophilisation concern a different glass family from Type I borosilicate. Freeze-related delamination described for Type 1A borosilicate vials is also a specific report, not a universal rate. Keep separate rows for glass family and for the cycle the container actually saw. Bridge with data on the lot in hand if a comparison is required.
How is delamination different from scratch damage?
Delamination releases thin flakes from a chemically altered inner surface. Scratch damage is mechanical. It can defeat a compressive layer on a chemically strengthened vial and can shed chips. Both can put glass particles in a lyophilised peptide unit, but the investigation differs. Flakes call for surface chemistry, vial lot, and the freeze or solution history. Chips call for handling, overpack breakage, and whether strengthening was declared. Elemental composition distinguishes glass from cake fragments.
What closure details should sit beside the glass class?
Polymer name as printed, commonly chlorobutyl or bromobutyl, plus liner if any, closure lot, and the sterilisation process actually applied. A published method covers borosilicate vials and both of those rubbers, but the lot record must name the cycle used, not a generic Type I assumption. Add stopper blanks to residual-solvent and mass-spectrometry sequences so leachables are not filed as peptide related substances. Glass class does not measure moisture crossing the closure.
References
- DOI:10.5731/pdajpst.2013.00925 — Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations — PDA Journal of Pharmaceutical Science and Technology — 2013
- DOI:10.1557/jmr.1995.1312 — Devitrification inhibitors in borosilicate glass and binary borosilicate glass composite — Journal of Materials Research — 1995
- DOI:10.21608/ejchem.2021.54579.3139 — Preparation and characterization of high chemical durability and low thermal expansion borosilicate glass-ceramics by recycling of borosilicate glass — Egyptian Journal of Chemistry — 2021
- DOI:10.53902/sojmccr.2025.05.000532 — Changes in Aluminosilicate Glass Vials During Lyophilyzation — SOJ Medical and Clinical Case Reports — 2025
- DOI:10.1134/s1087659621020097 — Analytical TEM Observation of the Flame-Ablated Surface of Borosilicate-Glass Vials — Glass Physics and Chemistry — 2021
- DOI:10.1016/j.oceram.2024.100689 — Ion-exchange enhancement of borosilicate glass vials for pharmaceutical packaging — Open Ceramics — 2024
- DOI:10.1016/j.jnoncrysol.2025.123596 — Enhancing borosilicate glass vials through chemical strengthening — Journal of Non-Crystalline Solids — 2025
- DOI:10.1016/j.jnoncrysol.2025.123871 — Assessing the reliability of chemically strengthened borosilicate glass vials under simulated scratching conditions — Journal of Non-Crystalline Solids — 2026
- DOI:10.18321/ectj1564 — Sterilization Method for Borosilicate Glass Vials and Chlorobutyl, Bromobutyl Rubbers for Medical Purposes — Eurasian Chemico-Technological Journal — 2024
Research use only
This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.
